Skip to main content
OpenTrials
Completed

NCT Number: NCT02294318

HealthCall-S: A Pilot Study Targeting Concurrent Non-injection Drug Use and Alcohol in HIV Primary Care Clinics

This pilot study goal is to compare two different treatments to help HIV positive patients reduce their concurrent drinking and non-injection drug use.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Alcohol or Other Drugs Use Chemically-Induced Disorders Mental Disorders Substance-Related Disorders

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

The New York State Psychiatric Institute

New York, 10032, United States

About this study

The goal of this study is to compare the effects of brief motivational interviewing with participation in HealthCall to brief motivational interviewing alone on non-injection drug and alcohol use. HealthCall involves 2-3 minutes of daily smartphone use to track drug use, drinking behaviors and other aspects of health, followed by personalized feedback in a graph after 30 and 60 days of using the smartphone.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Age 18 and older; 2. During the prior 30 days, > 4 days of non-injection of cocaine, methamphetamine or heroin, one of which is identified by the patient as his/her primary drug During prior 30 days, > 1 day of binge drinking (>4 drinks on one occasion); Completion of medically supervised detoxification if such detoxification is required; HIV Positive ; Able to give informed consent

Exclusion criteria

Patient is currently psychotic, suicidal, or homicidal. Patient has injected any drug in the last 6 months Patient has definite plans to leave the greater New York metropolitan area within the study period.

Patient has gross cognitive/psychomotor impairment as evidenced on the Halstead-Reitan Trails (A+B) Patient does not speak English or Spanish Patient has a hearing and/or vision impairment that precludes smartphone use.

-

Treatment and study plan

HealthCall+Motivational Interviewing

Behavioral

HealthCall is a technology-based enhancement to brief MI to improve behavior outcomes. It is introduced to patients by the study counselor at the end of the MI session.

Other names: MI+HealthCall

Motivational Interviewing

Behavioral

Motivational Interviewing is a client-centered counseling approach for eliciting behavior change.

Primary outcomes

  1. Mean Number of Days Used Primary Drug (NumDU)

    Time frame: 60 days

    This outcome was derived from a Timeline Follow Back (TLFB) completed at the end of the intervention (day 60).

  2. Mean Dollar Amount Spent Per Day on Primary Drug (QuantU)

    Time frame: 60 days

    This outcome was derived from a Timeline Follow Back (TLFB) completed at the end of the intervention (day 60).

  3. Mean Number of Drinking Days (NumDD)

    Time frame: 60 days

    This outcome was derived from a Timeline Follow Back (TLFB) completed at the end of the intervention (day 60).

  4. Mean Number of Drinks Per Day (QuantDD)

    Time frame: 60 days

    This outcome was derived from a Timeline Follow Back (TLFB) completed at the end of the intervention (day 60).

Sponsors and collaborators

Lead sponsor

Research Foundation for Mental Hygiene, Inc.

Other

Registry information

Official study title

HealthCall: Brief Intervention to Reduce Drug Use in HIV Primary Care

Important dates

Study start
2015
Primary completion
2016
Study completion
2016
First posted
Nov 19, 2014
Registry last updated
Aug 17, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.